If you are wondering what the procedure and guidelines are for the percutaneous coronary intervention, the National Guideline Clearinghouse of the U.S. Department of Health and Human Services has provided a thorough summary. Below is a brief excerpt from the guideline:
Patients with coronary artery disease
Management/Treatment
- Percutaneous coronary interventions (PCI), including percutaneous transluminal coronary angioplasty (PTCA), balloon expandable stents, drug-eluting stents, extraction atherectomy, directional coronary atherectomy, rotational atherectomy, rheolytic thrombectomy catheter, proximal and distal embolic protection devices, excimer laser coronary atherectomy, and local radiation devices to reduce in-stent restenosis
- Insurance of institutional and operator competency in performing PCI (quality assurance programs, high-volume operators in high-volume institutions, availability of onsite cardiac surgical back-up or access to cardiac surgical back-up)
- Antiplatelet and antithrombotic adjunctive therapies (aspirin, clopidogrel, glycoprotein IIb/IIIa Inhibitors, unfractionated heparin, low-molecular-weight heparin, bivalirudin) in patients undergoing PCI
- Special considerations (for example, management of clinical restenosis, ad hoc PCI, PCI in the cardiac transplant patient, and restenosis after stent implantation)
- Post-PCI management (postprocedural evaluation of ischemia, risk factor modification, exercise testing, follow-up coronary angiography)
Evaluation/Follow-up
- Angiographic assessment
- Use of adjunctive technologies
- Coronary intravascular ultrasound imaging (IVUS)
- Measurement of coronary flow velocity and coronary vasodilatory reserve
- Measurement of coronary artery pressure and fractional flow reserve (FFR)
- Measurement of creatine kinase-MB isoenzyme and troponins I or T
For a complete guideline, please visit the website here.






Our Readers Speak